Researchers are working overtime to develop therapies that, for the first time, specifically target Guillain-Barré Syndrome.

What is Guillain-Barré syndrome? Guillain-Barré syndrome (GBS) is also called acute inflammatory demyelinating polyradiculoneuropathy (AIDP). It's a neurological disorder in which the body's immune ...

Guillain-Barre Syndrome (pronounced Gee-luhn-Baa Syndrome) or GBS is a rare autoimmune condition in which the immune system attacks the peripheral nerves. It leads to symptoms such as numbness ...

An ongoing open-label, single arm, POC study is evaluating ANX1502 in patients with cold agglutinin disease (CAD) for up to four weeks to evaluate tolerability, pharmacokinetics, pharmacodynamic and ...

The GBS | CIDP Foundation International has unveiled survey data that paints a sobering picture of the physical, social, and financial challenges faced by individuals with Guillain-Barré Syndrome ...

“We have seen patients where they don’t know what the trigger was, but most often you typically hear about the preceding infection of some kind,” said Donna Hartlem, the executive director of GBS/CIDP ...

The full GBS Patient Registry Report is available here.You can watch recordings of this year's State of the Science meetings here. For more information, please visit www.gbs-cidp.org or contact ...

There have been reports of patients who have been started on peritoneal dialysis who developed CIDP shortly after. There is much that we are still learning about chronic inflammatory demyelinating ...